Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America Securities analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology (NASDAQ: SANA) and set a price target of $6.00. Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength Pressmaster/Shutterstock.com TD Cowen analyst Marc Frahm also maintained a Buy rating on Sana Biotechnology Inc., citing the company’s decision to focus on its high‑potential S ...